Diagnosis of Duchenne/Becker muscular dystrophy and quantitative identification of carrier status by use of entangled solution capillary electrophoresis.
A comprehensive repertoire of PCR-based assays has been reported that allows quantitative gene dosage analysis [21-24]. Briefly, the defect responsible for the disease is initially detected by a PCR reaction that remains within the logarithmic phase of amplification. The PCR product from a coamplified control exon is quantified after ethidium bromide staining  or densitometric scans of autoradiograms . Different fluorescent labeling strategies to identify deletion carriers have also been described [23-26]. The combination of fluorescent labeling, laser-induced fluorescence (LIF) detection, and automated, quantitative assessment yields sensitivity ~1000 times greater than ethidium bromide detection with a routine UV transilluminator.
Quantitative analysis of PCR products has many applications, e.g., carrier status identification of inherited diseases among family members , monitoring efficiency of nucleic acid amplification , and quantification of specific mRNA . The numerous methods developed to quantify the PCR-amplified products include DNA hybridization with chemiluminescence detection , slab gel electrophoresis with fluorescence detection , HPLC with UV detection , and oligodeoxynucleotide ligation assay with ELISA detection . However, these methods are either labor intensive, time consuming, costly, or hazardous.
Capillary electrophoresis (CE) has been quickly established as an efficient analytical tool . A typical CE system consists of two electrolyte chambers connected by a separation column, an on-line detector positioned close to the outlet of the capillary, and a high-voltage direct current power supply. The sample (~5 nL) can be introduced into the column either by electromigration or by differential pressure including applied pressure or vacuum. After the sample is loaded, high voltage is applied to the two electrodes inside the electrolyte chambers to establish an electric field across the capillary column. This can rapidly separate samples with high resolution. In many cases, the resolution limit and speed are determined by the Joule heating produced by operating at high power levels. To dissipate the heat efficiently, narrow capillaries of ~35-100 [micro]m (i.d.) are usually used. Under such conditions, plate counts well in excess of 500 000 for individual peaks, and at times >[10.sup.6], are readily attainable. Compared with conventional slab gel electrophoresis, CE has advantages of automation, qualitative and quantitative results, high resolution, rapid analysis, and low sample volume/reagent consumption. The technique has been applied widely to the separation of a diverse range of compounds, including large biomolecules such as proteins and DNA. CE has been used for nucleic acid analyses in mutation detection [34 -37], disease diagnosis [38-46], forensic investigations [47- 49], and pharmaceutical quality control [50 -52]. It has also been used for quantifying PCR-amplified products [53, 54] and ribonucleotides . In some of these applications, separation has been achieved by using entangled solution CE (ESCE) in physically and chemically entangled sieving matrices based on non-cross-linked polyacrylamide, hydroxypropylmethyl cellulose (HPMC), or hydroxyethyl cellulose polymers [35-37, 46].
We report the first example of the use of ESCE and LIF detection for quantitative analysis of multiplex PCR products to identify the carrier status of subjects for DMD/ BMD. This approach has great potential for increasing the speed, resolution, and sensitivity for diagnosing DMD/ BMD compared with conventional methods, and serves as a practical model for the determination of carrier status for many other genetic diseases.
Materials and Methods
High-molecular-mass DNA was extracted from peripheral blood leukocytes by the previously described protocol . Clinical samples included DNA from normal female controls, affected males with deletional forms of DMD/BMD, unrelated obligate carriers containing deletions in the dystropin gene, and female family members at risk for being carriers. DMD/BMD genotypes were previously determined .
DNA concentrations were adjusted to 50 mg/L (50 ng/[micro]L), and 100 ng of the template was used in a total reaction volume of 50 [micro]L. PCR amplifications were for 23 and 25 cycles, in either a Perkin-Elmer (Norwalk, CT) GeneAmp System 480 or a 9600 thermal cycler, essentially as previously described [9, 10].
ESCE was performed on the P/ACE system 5010 with a LIF detector (Beckman, Fullerton, CA) in the reversed polarity mode (negative potential at the injection end of the capillary column). The excitation and the emission wavelengths were 488 and 520 nm, respectively. The external temperature of the capillary column was set at 20[degrees]C.
Before analysis, 1 [micro]L of the multiplexed PCR products was removed from the reaction and diluted with 8 [micro]L of deionized distilled water plus 1 [micro]L of PCR product encompassing the [beta]-globin gene region. Sample injections were conducted under the conditions specified in each figure legend, and the separation was performed at a field strength of 296 V/cm for 11 min in 90 mmol/L Tris-base, 90 mmol/L boric acid, and 2 mmol/L EDTA, pH 8.4, containing 5.0 mL/L glycerol and 5 g/L HPMC (H-7509; Sigma Chemical Co., St. Louis, MO). The viscosity of a 20 g/L aqueous solution of this cellulose derivative was 4000 cP at 25[degrees]C. HPMC was dissolved in the buffer by the method recommended by Ulfelder et al. . The buffer was filtered through a 4.0-mm (pore size) filter and then degassed for 15 min by sonication. Fluorescent dye was made up daily by adding YO-PRO-1 (Molecular Probes, Eugene, OR) to the above buffer to a final dilution of 1:1000.
Samples were analyzed with a surface-modified fusedsilica capillary (DB-1; J&W Scientific, Folsom, CA). Postrun analysis of the data was performed with the Gold Chromatography Data System (Version 8.0; Beckman). The capillary column (27 cm x 100 mm) was conditioned with ~10 mL of distilled water followed by ~10 [micro]L of separation buffer and then was subjected to voltage equilibration for 30 min until a stable baseline was achieved. After each run, the column was washed with fresh separation buffer for 42 s.
Results and Discussion
SEPARATION OF PCR PRODUCTS BY CE
The entangled separation media used in this study were the cellulose derivative HPMC and glycerol, the combination of which has both physically and chemically entangled sieving pores of different sizes and a relatively high viscosity . This system has a high resolving power, provides rapid separation, and has been used for detecting mutations [35, 36]. An electropherogram of multiplex PCR products generated with the protocol reported by Beggs et al.  for the diagnosis of BMD is shown in Fig. 1. All nine products were well resolved to baseline in <10 min. In comparison, the results previously reported  had a separation time of 50 min and produced only partial separation. An electropherogram of nine normal exons from a normal female is shown in Fig. 1A. Results from an affected male patient (Fig. 1B), in comparison, clearly shows deletion of exons 13 and 43. Separation of the mixed products from multiplexed PCR reactions by using the Chamberlain (exon 4 = 196 bp; exon 8 = 360 bp; exon 12 = 331 bp; exon 17 = 416 bp; exon 19 = 459 bp; exon 45 = 547 bp; exon 48 = 506 bp; exon 51 = 388 bp) and the Beggs protocols is shown in Fig. 2. Sixteen of 18 products were separated in 10 min--compared with 70 min reported with use of a low-viscosity polyacrylamide sieving polymer solution . Each of the samples injected for CE was a dilution of the original PCR products (1 [micro]L of sample diluted by 9 mL of water). Although the current separation system failed to resolve the 535- and 547-bp fragments (12-bp difference), it may be possible to resolve these two fragments by increasing the concentration of glycerol in the separation media . LIF detection (with the intercalating fluorescent monomer dye YOPRO-1) was ~100-fold more sensitive than the UV absorbance method used for on-line detection of the DNA molecules.
[FIGURE 1 OMITTED]
QUANTITATIVE IDENTIFICATION OF CARRIER STATUS
System optimization. A battery of multiplexed PCR products was used to investigate the optimal injection conditions for quantitative PCR analysis. The test consisted of a run of four batches, with each batch containing eight identical samples. The samples were injected at 5 kV for 3, 5, 7, and 9 s. The averaged reproducibility (CV) for each injection condition is shown in Fig. 3 as both corrected CVs and uncorrected CVs. The corrected CVs were obtained by using 196-, 331-, 416-, and 547-bp fragments (for the respective injection times) as internal standards for the postrun correction of the peak area.
[FIGURE 2 OMITTED]
[FIGURE 3 OMITTED]
The lowest CV was achieved for the 7-s injection at 5 kV. As indicated in Fig. 3, the most accurate postrun correction (0.59% average CV) was obtained by using the peak area of the 416-bp fragment as the internal standard. The next most accurate correction (0.76% average CV) was obtained by using the peak area standardized to the 547-bp fragment (the largest fragment). From these results and the convenience of selecting an internal control that does not overlap with any of the actual sample fragments, we chose a 756-bp PCR-amplified DNA fragment as the internal standard and an optimal injection condition of 7 kV for 5 s for the subsequent quantitative determination of carrier status of DMD/BMD.
[FIGURE 4 OMITTED]
[FIGURE 5 OMITTED]
Quantitative identification of carrier status. We used the same quantity of sample DNA for PCR reactions. Superimposed electropherograms of a normal female and a normal male are shown in Fig. 4. The peak for every product was automatically identified by its fragment size, and the peak areas were corrected with use of the 756-bp fragment as internal standard. A plot of the corrected peak areas vs the size of each fragment (Fig. 5) clearly showed that the peak areas of the amplification products for the normal female are about double those for the normal male, as expected for an X-linked gene. The superimposed electropherograms from both a normal female and a female carrier are shown in Fig. 6. The ratio of the corrected peak areas of samples A and B (Fig. 7) makes evident that sample B is from a female carrier because of a deletion at exon 45 (547 bp) on one X chromosome, leading to a 50% reduction in the peak area for the 547-bp fragment.
[FIGURE 6 OMITTED]
[FIGURE 7 OMITTED]
In conclusion, as both Fig. 5 and Fig. 7 illustrate, accurate quantitative determination of X-linked DMD/BMD carrier status can be achieved with the PCR-quantitative CE analytical system reported here. In addition, this study indicates how the ESCE method could be used to screen for suspected carrier females in families when DNA samples from affected males are not available. This is estimated to be relevant in ~20% of families with an X-linked lethal disorder such as DMD/BMD. Unlike other methods [49, 57], prepurification or dialysis of the PCR sample is not required, greatly simplifying sample preparation for quantitative CE analysis. To achieve maximum performance for production of quantitative results, the following requirements must be met. First, the quality and quantity of the template prepared from different samples must be consistent. Second, optimization of the operational conditions must be reestablished when system features, e.g., capillary coating and dimensions, separation medium, and manufacturers, are changed. Components of the present separation system can be easily coupled for use with a capillary array electrophoresis system [59, 60], which should have a much higher sample-throughput capability than any of the currently used systems.
We thank Beckman Instruments for the loan of the P/ACE 5010 and the LIF detector. Some of the work was supported by the Department of Pathology and Clinical Laboratory, The Children's Hospital of Philadelphia (W.H., P.F.), and by a Sponsored Research Agreement from Caliper Technologies Corp. to P.W. and L.J.K. and the University of Pennsylvania, with full endorsement by the Conflicts of Interest Committee of the University of Pennsylvania. P.W. and L.J.K. hold minority stock in Caliper Technologies Corp.
Received October 21, 1996; revised and accepted December 5, 1996.
[1.] Moser H. Duchenne muscular dystrophy: pathogenic aspects and genetic prevention. Hum Genet 1984;66:17-40.
[2.] Koenig M, Hoffman E, Betelson C, Monoaio A, Feener C, Kunkel L. Complete cloning of Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals. Cell 1987;50:509-17.
[3.] Hodgson SV, Hart K, Abbs S, Heckmatt J, Rodillo E, Bobrow M, et al. Correlation of clinical and deletion data in Duchenne and Becker muscular dystrophy. J Med Genet 1989;26:682-93.
[4.] Koenig M, Beggs AH, Moyer M, Scherpf S, Heindrich K, Bettecken T, et al. The molecular basis for Duchenne versus Becker muscular dystrophy: correlation of severity with type of deletion. Am J Hum Genet 1989;45:498-506.
[5.] Forrest SM, Cross GS, Speer A, Gardener-Medwin D, Burn J, Davies KE. Preferential deletion of exons in Duchenne and Becker muscular dystrophies. Nature 1987;329:638-40.
[6.] Forrest SM, Cross GS, Flint T, Speer A, Robson KJH, Davies KE. Further studies of gene deletions that raise Duchenne and Becker muscular dystrophies. Genomics 1988;2:109-14.
[7.] Hu X, Ray PN, Murphy E, Thompson M, Worton RG. Duplicational mutation at the Duchenne muscular dystrophy locus: its frequency, distribution, origin and phenotype genotype correlation. Am J Hum Genet 1990;46:682-95.
[8.] Murphy EA, Mutalik GS. The application of Bayesian methods in genetic counseling. Hum Hered 1989;19:126-51.
[9.] Chamberlain JS, Gibbs RA, Rainier JE, Caskey CT. Multiplex PCR for the diagnosis of Duchenne muscular dystrophy. In Innis M, Gelfand D, Sninski J, White T, eds. PCR protocols: a guide to methods and applications. Orlando, FL: Academic Press, 1990: 272-81.
[10.] Beggs AH, Koenig M, Boyce FM, Kunkel LM. Detection of 98% of DMD/BMD gene deletions by polymerase chain reaction. Hum Genet 1990;86:45-8.
[11.] Abbs S, Yau SC, Clark S, Mathew CG, Bobrow M. A convenient multiplex PCR system for the detection of dystrophin gene deletions: a comparative analysis with cDNA hybridization reveals mistyping by both methods. J Med Genet 1991;28:304-11.
[12.] Chamberlain JS, Chamberlain JR, Fenwick RG, Ward PA, Caskey CT, Dimnik LS, et al. Diagnosis of Duchenne and Becker muscular dystrophies by polymerase chain reaction. JAMA 1992;267: 2609-15.
[13.] Katayama S, Montano M, Slotnick RN, Lebo RV, Golbus MS. Prenatal diagnosis and carrier detection of Duchenne muscular dystrophy by restriction fragment length polymorphism analysis with pERT 87 deoxyribonucleic acid probes. Am J Obstet Gynecol 1988;158:548-55.
[14.] Heijtmancik JR. Carrier diagnosis of Duchenne muscular dystrophy using restriction fragment length polymorphism. Neurology 1986;36:1553-62.
[15.] Clements PR, Fenwick RG, Chamberlain JS, Gibbs RA, De Andrade M, Chakraborty R, et al. Carrier detection and prenatal diagnosis in Duchenne and Becker muscular dystrophy families using dinucleotide repeat polymorphisms. Am J Hum Genet 1991;49:951-60.
[16.] den Dunnen JT, Bakker E, Klein Breteler EG, Pearson PL, van Ommen GJB. Direct detection of more than 50% of the Duchenne muscular dystrophy mutations by field inversion gels. Nature 1987;329:640-2.
[17.] Blonden LAJ, den Dunnen JT, van Passen HMB, Wapenaar MC, Grootscholten PM, Ginjaar HB, et al. High resolution deletion breakpoint mapping in the DMD gene by whole cosmid hybridization. Nucleic Acids Res 1989;17:5611-21.
[18.] Mao Y, Cremer M. Detection of Duchenne muscular dystrophies carriers by dosage analysis using the DMD cDNA clone 8. Hum Genet 1989;81:193-5.
[19.] Roberts RG, Bentley DR, Barby TM, Manners E, Bobrow M. Direct diagnosis of carriers of Duchenne and Becker muscular dystrophy by amplification of lymphocyte DNA. Lancet 1990;ii:1523-6.
[20.] Roberts RG, Barby TM, Manners E, Bobrow M, Bentley DR. Direct detection of dystrophyn gene rearrangements by analysis of dystrophyn mRNA in peripheral blood lymphocytes. Am J Hum Genet 1991;49:298-310.
[21.] Prior TW, Papp AC, Snyder PJ, Highsmith WE, Friedman KJ, Perry TR, et al. Determination of carrier status in Duchenne and Becker muscular dystrophies by quantitative polymerase chain reaction and allele-specific oligonucleotides. Clin Chem 1990;36:2113-7.
[22.] Abbs S, Bobrow M. Analysis of quantitative PCR for the diagnosis of deletion and duplication carriers in the dystrophin gene. J Med Genet 1992;29:191-6.
[23.] Schwartz LS, Trarleton J, Popovich B, Seltzer WK, Hoffman EP. Fluorescent multiplex linkage analysis and carrier detection for Duchenne/Becker muscular dystrophy. Am J Hum Genet 1992; 51:721-9.
[24.] Mansfield ES, Robertson JM, Lebo RV, Lucero MY, Mayrand PE, Rappaport E, et al. Duchenne/Becker muscular dystrophy carrier detection using quantitative PCR and fluorescent-based strategies. Am J Med Genet 1993;48:200-8.
[25.] Yau SC, Bobrow M, Mathew CG, Abbs SJ. Accurate diagnosis of carriers of deletions and duplications in Duchenne/Becker muscular dystrophy by fluorescent dosage analysis. J Med Genet 1996;33:550-8.
[26.] Brown CA, Sutherland JE, Ray PNL. Duchenne/Becker muscular dystrophy (DMD/BMD) carrier analysis utilizing computer assisted laser densitometry [Abstract]. Am J Hum Genet 1992;51:209.
[27.] Mansfield ES, Blasband A, Kronick MN, Wrabetz L, Kaplan P, Rappaport E, et al. Fluorescent approaches to diagnosis of Lesch-Nyhan syndrome and quantitative analysis of carrier status. Mol Cell Probes 1993;7:311-24.
[28.] Yang B, Yolken R, Viscidi R. Quantitative polymerase chain reaction by monitoring enzymatic activity of DNA polymerase. Anal Biochem 1993;208:110-6.
[29.] Dupla C, Couffinhal T, Labat L, Moreau C, Lamaziare J-MD, Bonnet J. Quantitative analysis of polymerase chain reaction products using biotinylated dUTP incorporation. Anal Biochem 1993;212: 229-36.
[30.] Berndt C, Bebenroth M, Oehlschlegel K, Hiepe F, Schossler W. Quantitative polymerase chain reaction using a DNA hybridization assay based on surface-activated microplates. Anal Biochem 1995;225:252-7.
[31.] van Hille B, Lohri A, Reuter J, Herrmann R. Non-radioactive quantification of mdr1 mRNA by polymerase chain reaction amplification coupled with HPLC. Clin Chem 1995;41:1087-93.
[32.] Friedhoff P, Hahn M, Wolfes H, Pingoud A. Quantitative polymerase chain reaction with oligodeoxynucleotide ligation assay/ enzyme-linked immunosorbent assay detection. Anal Biochem 1993;215:9-16.
[33.] Krull IS, Mazzeo JR. Capillary electrophoresis: the promise and the practice [Product Review]. Nature 1992;357:92-4.
[34.] Khrapko O, Hanekamp JS, Thilly WG, Belenkii A, Foret F, Karger BL. Constant denaturant capillary electrophoresis (CDCE): a high resolution approach to mutational analysis. Nucleic Acids Res 1994;22:364-9.
[35.] Cheng J, Kasuga T, Mitchelson KR, Lightly ERT, Watson ND, Martin WJ, et al. PCR heteroduplex polymorphism analysis by entangled solution capillary electrophoresis (ESCE). J Chromatogr A 1994;677:169-77.
[36.] Cheng J, Kasuga T, Watson ND, Mitchelson KR. Enhanced single strand DNA conformation polymorphism analysis by entangled solution capillary electrophoresis (ESCE). J Cap Electrophoresis 1995;2:24-9.
[37.] Cheng J, Shoffner MA, Mitchelson KR, Kricka LJ, Wilding P. Analysis of ligase chain reaction products amplified in a silicon-glass chip using capillary electrophoresis. J Chromatogr A 1996; 732:151-8.
[38.] Schwartz HE, Ulfelder K. Analysis of DNA restricted fragments and polymerase chain reaction products towards detection of the AIDS (HIV-1) virus in blood. J Chromatogr 1991;559:267-83.
[39.] Nesi M, Righetti PG, Patrosso MC, Ferlini A, Chiari M. Capillary electrophoresis of polymerase chain reaction-amplified products in polymer networks: the case of Kennedy's disease. Electrophoresis 1994;15:644-6.
[40.] Gelfi C, Orsi A, Righetti PG, Zanussi M, Carrera P, Ferrari M. Capillary zone electrophoresis in polymer networks of polymerase chain reaction-amplified oligonucleotides: the case of congenital adrenal hyperplasia. J Chromatogr B 1994;657:201-5.
[41.] Arakawa H, Uetanaka K, Maeda M, Tsuji A, Matsubara Y, Narisawa K. Analysis of polymerase chain reaction-product by capillary electrophoresis with laser-induced fluorescence detection and its application to the diagnosis of medium-chain acyl-coenzyme A dehydrogenase deficiency. J Chromatogr A 1994;680:517-23.
[42.] Gelfi C, Orsi A, Righetti PG, Brancolini V, Cremonesi L, Ferrari M. Capillary zone electrophoresis of polymerase chain reaction-amplified DNA fragments in polymer networks: the case of GATT microsatellites in cystic fibrosis. Electrophoresis 1994;15: 640-3.
[43.] Gelfi C, Righetti PG, Brancolini V, Cremonesi L, Ferrari M. Capillary electrophoresis in polymer networks for analysis of PCR products: detection of DF508 mutation in cystic fibrosis. Clin Chem 1994; 40:1603-5.
[44.] Rossomando EF, White L, Ulfelder KJ. Capillary electrophoresis: separation and quantitation of reverse transcriptase polymerase chain reaction products from polio virus. J Chromatogr B 1994; 656:159-68.
[45.] Evans MD, Wolfe JT, Perrett D, Lunec J, Herbert KE. Analysis of internucleosomal DNA fragment in apoptotic thymocytes by dynamic sieving capillary electrophoresis. J Chromatogr A 1995; 700:151-62.
[46.] Gelfi C, Orsi A, Leoncini F, Righetti PG, Spiga I, Carrera P, et al. Amplification of 18 dystrophin gene exons in DMD/BMD patients: simultaneous resolution by capillary electrophoresis in sieving liquid polymers. BioTechniques 1995;19:254-63.
[47.] McCord BR, Butler JM, Jung JM, Budowle B, Allen RO. Application of dual internal standards for precise sizing of polymerase chain reaction products using capillary electrophoresis. Electrophoresis 1995;16:974-80.
[48.] Wang Y, Ju J, Carpenter BA, Atherton JM, Sensabaugh GF, Mathies RA. Rapid sizing of short tandem repeat alleles using capillary array electrophoresis and energy-transfer fluorescence primers. Anal Chem 1995;67:1197-203.
[49.] Williams PE, Marino MA, del Rio SA, Turni LA, Devaney JM. Analysis of DNA restriction fragments and polymerase chain reaction products by capillary electrophoresis. J Chromatogr A 1994;680:525-40.
[50.] Bruin GJM, Bornsen KO, Husken D, Gassmann E, Widmer HM, Paulus A. Stability measurements of antisense oligonucleotides by capillary gel electrophoresis. J Chromatogr A 1995;709:181-95.
[51.] Rose DJ. Characterization of antisense binding properties of peptide nucleic acids by capillary gel electrophoresis. Anal Chem 1994;65:3545-9.
[52.] Belenky A, Smisek DL, Cohen AS. Sequencing of antisense DNA analogues by capillary gel electrophoresis with laser-induced fluorescence detection. J Chromatogr A 1995;700:137-49.
[53.] Butler JM, McCord BR, Jung JM, Wilson MR, Budowle B, Allen RO. Quantitation of polymerase chain reaction products by capillary electrophoresis using laser fluorescence. J Chromatogr B 1994; 658:271-80.
[54.] Fasco MJ, Treanor CP, Spivack S, Figge HL, Kaminsky LS. Quantitative RNA-polymerase chain reaction products by capillary electrophoresis using laser fluorescence. Anal Biochem 1995; 224:140-7.
[55.] Huang M, Liu S, Murray BK, Lee ML. High performance separation and quantitation of ribonucleotides using capillary electrophoresis. Anal Biochem 1992;207:231-5.
[56.] Poncz M, Solowiejzcyk D, Harpel B, Mory Y, Schwartz E, Surrey S. Construction of human gene libraries from small amounts of peripheral blood: analyses of b-like globin genes. Hemoglobin 1982;6:27-36.
[57.] Ulfelder KJ, Schwartz H E, Hall JM, Sunzeri FJ. Restriction fragment length polymorphism analysis of ERBB2 oncogene by capillary electrophoresis. Anal Biochem 1992;200:260-7.
[58.] Cheng J, Mitchelson KR. Glycerol-enhanced separation of DNA fragments in entangled solution capillary electrophoresis. Anal Chem 1994;66:4210-2.
[59.] Clark SM, Mathies RA. High-speed parallel separation of DNA restriction fragment using capillary array electrophoresis. Anal Biochem 1993;215:163-70.
[60.] Mansfield ES, Veiner M, Enad S, Baker DL, Rappaport E, Fortina P. Sensitivity, reproducibility and accuracy in short tandem repeat genotyping using capillary array electrophoresis. Genome Res 1996;6:893-903.
PAOLO FORTINA, (1) *, JING CHENG (2), MANN A. SHOFFNER (2), SAUL SURREY, (1) WENDY M. HITCHCOCK, (3) LARRY J. KRICKA, (2) and PETER WILDING (2)
(1) Department of Pediatrics, The Children's Hospital of Philadelphia, University of Pennsylvania School of Medicine, Philadelphia, PA.
(2) Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine.
(3) Department of Pathology and Clinical Laboratories, The Children's Hospital of Philadelphia.
(4) Nonstandard abbreviations: DMD, Duchenne muscular dystrophy; BMD, Becker muscular dystrophy; ESCE, entangled solution capillary electrophoresis; CE, capillary electrophoresis; LIF, laser-induced fluorescence detection; and HPMC, hydroxypropylmethyl cellulose.
* Address correspondence to this author, at: The Children's Hospital of Philadelphia, 310-C Abramson Pediatric Research Center, 34th St. and Civic Center Blvd., Philadelphia, PA 19104-4318. Fax 215-590-3660; e-mail firstname.lastname@example.org.
|Printer friendly Cite/link Email Feedback|
|Title Annotation:||Molecular Pathology|
|Author:||Fortina, Paolo; Cheng, Jing; Shoffner, Mann A.; Surrey, Saul; Hitchcock, Wendy M.; Kricka, Larry J.;|
|Date:||May 1, 1997|
|Previous Article:||Microdialysis-HPLC for plasma levodopa and metabolites monitoring in parkinsonian patients.|
|Next Article:||Quantitative polymerase chain reaction-based homogeneous assay with fluorogenic probes to measure c-erbB-2 oncogene amplification.|